Chase Reece, BSHP '24

Today, I focused specifically on examining the results of collaborative drug therapy management pilot programs. CDTM has been implemented in a wide variety of clinical settings, including hospital care, primary care, specialty care. One of the most comprehensive CDTM pilot programs I identified today was a CDTM trial in an gynecology oncology clinic and consisted of a total of 54 patient consultations over a four-month trial period. Additionally, there was a 100% survey response rate from physicians and 98% response rate after the program, which helps give credibility to the results. Overall, the study found that the most interventions by the CDTM pharmacists were performing medication education, prescribing new medications, and changing the dosing or frequency of medications. Further, the CDTM pharmacists successfully identified 6 medication-related adverse events. The study also revealed that the CDTM program allowed pharmacist to identify specific barriers to medication adherence in their patients, and the barriers were resolved in the majority of patients, allowing them to continue their treatment protocol. Out of all the participants, 92% of patients had favorable views of the CDTM services received, including the quality of service and quality of pharmacist knowledge. All physicians reported favorable satisfaction with the quality of CDTM services, time and cost savings of CDTM, and increase in patient quality of care. This study highlights the beneficial outcomes of CDTM programs, as well as the favorable patient and physician views of such services. This emphasizes the need to educate both physicians and patients about the real-world applications and outcomes of CDTM in the clinical setting.